These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24374162)

  • 21. Modulation of calreticulin expression reveals a novel exosome-mediated mechanism of Z variant α
    Khodayari N; Oshins R; Alli AA; Tuna KM; Holliday LS; Krotova K; Brantly M
    J Biol Chem; 2019 Apr; 294(16):6240-6252. PubMed ID: 30833329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alpha-1 antitrypsin deficiency 50 years later].
    Mornex JF
    Bull Acad Natl Med; 2014; 198(4-5):757-66. PubMed ID: 26753407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.
    Miranda E; Ferrarotti I; Berardelli R; Laffranchi M; Cerea M; Gangemi F; Haq I; Ottaviani S; Lomas DA; Irving JA; Fra A
    FEBS J; 2017 Jul; 284(13):2110-2126. PubMed ID: 28504839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-1-antitrypsin deficiency: biochemistry and clinical manifestations.
    Perlmutter DH
    Ann Med; 1996 Oct; 28(5):385-94. PubMed ID: 8949968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the site encoded by SERPINA1*E342K for treating alpha-1 antitrypsin deficiency-associated liver diseases.
    Zhang X; Pham K; Li D; Schutte RJ; Brantly M; Liu C; Ostrov DA
    FEBS Lett; 2019 Jul; 593(14):1849-1862. PubMed ID: 31116417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency.
    Lomas DA
    COPD; 2013 Mar; 10 Suppl 1():17-25. PubMed ID: 23527623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of autophagy in alpha-1-antitrypsin deficiency.
    Hidvegi T; Mukherjee A; Ewing M; Kemp C; Perlmutter DH
    Methods Enzymol; 2011; 499():33-54. PubMed ID: 21683248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alpha-1-antitrypsin deficiency].
    Bouchecareilh M
    Med Sci (Paris); 2014 Oct; 30(10):889-95. PubMed ID: 25311024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-1-Antitrypsin Deficiency Liver Disease.
    Patel D; Teckman JH
    Clin Liver Dis; 2018 Nov; 22(4):643-655. PubMed ID: 30266154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins.
    Perlmutter DH
    Autophagy; 2006; 2(4):258-63. PubMed ID: 16874089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.
    Miranda E; Pérez J; Ekeowa UI; Hadzic N; Kalsheker N; Gooptu B; Portmann B; Belorgey D; Hill M; Chambers S; Teckman J; Alexander GJ; Marciniak SJ; Lomas DA
    Hepatology; 2010 Sep; 52(3):1078-88. PubMed ID: 20583215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review.
    Perlmutter DH; Brodsky JL; Balistreri WF; Trapnell BC
    Hepatology; 2007 May; 45(5):1313-23. PubMed ID: 17464974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum.
    Perlmutter DH
    Methods Mol Biol; 2003; 232():39-56. PubMed ID: 12840538
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
    Greene CM; Miller SD; Carroll T; McLean C; O'Mahony M; Lawless MW; O'Neill SJ; Taggart CC; McElvaney NG
    J Inherit Metab Dis; 2008 Feb; 31(1):21-34. PubMed ID: 18193338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
    Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
    J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of helix I and strand 5A in the folding, function and misfolding of α1-antitrypsin.
    Knaupp AS; Keleher S; Yang L; Dai W; Bottomley SP; Pearce MC
    PLoS One; 2013; 8(1):e54766. PubMed ID: 23382962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on alpha-1 antitrypsin deficiency: New therapies.
    Lomas DA; Hurst JR; Gooptu B
    J Hepatol; 2016 Aug; 65(2):413-24. PubMed ID: 27034252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nascent chains can form co-translational folding intermediates that promote post-translational folding outcomes in a disease-causing protein.
    Plessa E; Chu LP; Chan SHS; Thomas OL; Cassaignau AME; Waudby CA; Christodoulou J; Cabrita LD
    Nat Commun; 2021 Nov; 12(1):6447. PubMed ID: 34750347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.
    Burrows JA; Willis LK; Perlmutter DH
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1796-801. PubMed ID: 10677536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
    Teckman JH
    COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.